Diffuse liver disease. Evaluation with CT and MR imaging;La Tomografia Computerizzata e la Risonanza Magnetica nelle epatopatie diffuse

Radiologia Medica

Volumn 103, Issue 3, 2002, Pages 171-187

  Midiri, Massimo ^a,b   Bartolotta, Tommaso Vincenzo ^a   Lagalla, Roberto ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; HUMAN; LIVER DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; RADIOGRAPHY; REVIEW;

DIAGNOSIS, DIFFERENTIAL; HUMANS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0036515121     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (83)

1. Lagalla R, Bartolotta TV, Midin M: Epatopatie diffuse In: Ziviello M, Bazzocchi M (eds): Ecografia. Idelson-Gnocchi, Napoli, (in stampa).
2. Lagalla R, Iovane A, Bartolotta TV: Ecografia: pag. 976-1004. In: "Il nuovo Rasario Semeiotica e metodologia medica. Diciottesima 'edizione. Idelson, Napoli, 1996.
3. Abbitt P: Ultrasonography: update on liver technique. Radiol Clinic North Am 299-307, 1998.
4. Nazarian LN, Feld RI, Herrine SK et al. Safety and efficacy of sonographically guided random core biopsy for diffuse liver disease J Ultrasound Med 19: 537-541, 2000.
5. Murakami T, Kim T, Takamura M et al: Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 218: 763-767, 2001.
6. Foley WD, Mallisee TA, Hohenwalter MD et al: Multiphase hepatic CT with a multirow detector CT scanner. AIR 175: 679-685, 2000
7. Hu H, He HD, Foley WD et al: Four multi-detector row helical CT: image quality and volume coverage speed. Radiology 215: 55-52, 2000.
8. Kemmerer SR, Mortele KJ, Ros PR: CT scan of the liver. Radiol Clin North Am 36 247-261, 1998.
9. Bartolozzi C, Lencioni R, Donati F, Cioni D: Abdominal MR: liver and pancreas. In: Baert AL, Adam G, Debatin JF (eds) MRI - From basic knowledge to advanced strategies. Pag. 121-137, Springer-Verlag, Berlin, 2000
10. Siegelman ES, Outwater EK: MR Imaging techniques of the liver. Radiol Clin North Am 36: 263-286, 1998.
11. Hahn PF, Saini S: Liver-specific MR Imaging contrast agents. Radiol Clin North Am 36: 287-297, 1998.
12. Clement O, Siauve N, Cuénod CA et al: Mechanisms of action of liver contrast agents: impact for clinical use. J Comput Assist Tomogr 23: S45-S52, 1999.
13. Laniado M, Kopp AF: Liver-specific contrast media: a magic bullet or a weapon for dedicated targets? Radiology 205: 319-322, 1997.
14. Mahfouz AE, Hamm B, Taupitz M. Contrast agent for MR Imaging of the liver: a clinical overview. Eur Radiol 7: 507-513, 1997
15. Van Beers BE, Gallez B, Pringot J: Contrast-enhanced MR Imaging of the liver. Radiology 203: 297-306, 1997.
16. Baron RL. Understanding and optimizing use of contrast material for CT of the liver. AJR 163: 323-331, 1994
17. Giovagnoni A, Paci E, Valeri G et al: Fegato: RM tradizionale Radiol Med 91: 122-129, 1996
18. Midiri M, Sparacia G, Bartolotta TV et al: Risonanza magnetica nucleare, principi fisici. In: Hoffmann E, Midin M (eds) Risonanza magnetica cardiovascolare. Pag. 2-27 Gnocchi, Napoli 1996.
19. Villa A, Meloni G, Sammarchi L et al: Fegato: sequeme Fast e Ultrafast. Radiol Med 91 (Suppl 1 al n. 5): 130-136, 1996.
20. Nitz WR, Reimer P: Contrast mechanisms in MR imaging. In: Baert AL, Adam G, Debatin JF (eds) MRI - From basic knowledge to advanced strategies Pag 19-33, Springer-Verlag, Berlin, 2000.
21. Martin J, Sentis M, Puig J et al: Comparison of in-phase and opposed-phase GRE and conventional SE MR pulse sequences in T1-weighted imaging of liver lesions. J Comput Assist Tomogr 20: 890-897, 1996.
22. Siegelman ES, Mitchell DG, Rubin R et al: Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR Imaging. Radiology 179: 361-366, 1991.
23. Edelman RR, Wielopolski P, Schmitt F: Echo Planar MR Imaging Radiology 195: 600-612, 1995.
24. Henkelman RM, Hardy PA, Bishop et al: Why fat is bright m RARE and fast spin-echo imaging. J Magn Reson Imaging 2: 533-540, 1992
25. Schwartz LH, Seltzer SE, Tempany CM et al: Superparamagnetic iron oxide hepatic MR imaging: Efficacy and safety using conventional and fast spin echo-pulse sequences. J Magn Reson Imaging 5: 566-570, 1995.
26. Coates GG, Borello JA, McFarland EG et al: Hepatic T2-weighted MRI: Sequences, including breath-hold, half-Fourier turbo spin echo. J Magn Reson Imaging 8: 642-649, 1998
27. Morijiri M, Seto H, Kamisaki Y et al: Qualitative evaluation of chronic diffuse liver disease by STIR MRI. J Comput Assist Tomogr 19: 955-958, 1995.
28. Tang Y, Yamashita Y, Namimoto T et al. Liver T2-weighted MR imaging: Comparison of fast and conventional half-Fourier single-shot turbo spin echo, breath-hold turbo spin echo, and respiratory-triggered turbo spin echo sequences. Radiology 197: 766-772, 1997.
29. Anthony P, Ishak K, Nayak N et al: The morphology of cirrhosis. Reccomendations on definition, nomenclature and classification by a working group sponsored by World Health Organization. J Clin Pathol 31: 395-401, 1978.
30. Hanh Vu Nghiem J: Hepatic trasplant imaging. In: Freeny PC, Dodd III GD, Cooperberg PL, Ros PR (eds). Radiology of the liver, biliary tract and pancreas, pag 71-78, American Roentgen Ray Society, New York, 1996.
31. Macari M, Rofsky NM: Cirrhosis: MR Imaging update. Imaging decisions MRI 2: 2-10, 1998.
32. Bolondi L, Gaiani S, Casali A et al: Screening per la diagnosi precoce del carcinoma epatocellulare: rapporto costo-beneficio Radiol Med 94: 4-7, 1997.
33. Colombo M, De Franchis R, Del Nino E et al: Hepatocellular carcinoma in italian patients with cirrhosis. N Engl J Med 325: 675-679, 1991.
34. Mima S, Sekiya C, Kanagawa H et al: Mass screening of hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroent Epatol 9: 361-365, 1994.
35. Oka H, Kurioka N, Kim K et al: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis Hepatology 12: 680-687, 1990
36. Brown JJ, Naylor MJ, Yagan N. Imaging of hepatic cirrhosis. Radiology 202 1-16, 1997.
37. Siegelman ES, Outwater EK: Magnetic resonance imaging of focal and diffuse hepatic disease Semin Ultrasound CT MR 19; 2-34, 1998.
38. Dodd III GD: Imaging of cirrhosis. In: Freeny P, Dodd III GD, Cooperberg PL, Ros P (eds) Radiology of the liver, biliary tract and pancreas, pag 65-69, American Roentgen Ray Society, New York, 1996.
39. Urban BA, Fishman EK: Spiral CT of hepatic parenchymal disease. In: Fishman EK, Jeffrey RB (eds). Spiral CT principles, technique and clinical applications. Pag 143-158, Lippincott-Raven, Philadelphia, 1998.
40. Mergo PJ, Ros PR: Imaging of diffuse liver disease. Radiol Clin North Am 36: 365-375, 1998.
41. Heiken JP: Diffuse liver disease. In: Freeny P, Dodd III GD, Cooperberg PL, Ros P (eds) Radiology of the liver, biliary tract and pancreas, pag. 79-84, American Roentgen Ray Society, New York, 1996.
42. Winter TC. The multistep process of hepatocellular carcinogenesis in the setting of chronic liver disease. In: Freeny PC, Dodd III GD, Cooperberg PL, Ros PR (eds). Pag. 33-40: Radiology of the liver, biliary tract, and pancreas. American Roentgen Ray Society, New York, 1996.
43. Earls JP, Thiese ND, Weinreb HC et al: Dysplastic nodules and hepatocellular carcinoma, thin section MR imaging of explanted cirrhotic livers with pathologic correlation. Radiology 201: 207-212, 1996
44. Kanematsu M, Hoshi H, Yamada T et al: Small hepatic nodules m cirrhosis: ultrasonographic, CT, and MR imaging findings. Abdom Imaging 24: 47-55, 1999.
45. Dodd III GD, Baron RL, Oliver III JH, Federle MP: Spectrum of imaging findings of the liver in end-stage cirrhosis: Part II, focal abnormalities. AJR 173: 1185-92, 1999.
46. Mitchell DG: Focal manifestations of diffuse liver disease at MR Imaging. Radiology 185: 1-7, 1992.
47. Krinsky GA, Lee VS, Theise ND: Focal lesions in the cirrhotic liver: high resolution ex vivo MRI with pathological correlation. J Comput Assist Tomogr 24: 189-196, 2000.
48. Solbiati L, Cova L, Ierace T et al: Liver cancer imaging: the need for accurate detection of intrahepatic disease spread. J Comput Assist Tomogr 23: S29-S37, 1999.
49. Baron RL, Oliver JH, Dodd GD III et al: Hepatocellular carcinoma: evaluation with biphasic, contrast-enhanced, elical CT. Radiology 199: 505-511, 1996
50. Hollett MD, Jeffrey RB, Nino-Murcia M et al Dual phase helical CT of the liver: value of of arterial phase in the detection of small (less than 1 5 cm) malignant hepatic neoplasms. AJR 164: 879-884, 1995.
51. van Leeuwen MS, Noordzij J, Feldberg MAM et al: Focal liver lesions: characterization with triphasic spiral CT. Radiology 201: 327-336, 1996
52. Ebara M, Fukuda H, Kojima et al: Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma. Radiology 210: 81-88, 1999.
53. Kanematsu M, Hoshi M, Murakami T et al: Detection of hepatocellular carcinoma in patients with cirrhosis: MR imaging versus angiographically assisted helical CT. AJR 4: 83-90, 1997.
54. Dodd III GD, Baron RL, Oliver III JH, Federle MP: Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities AJR 173: 1031-6, 1999.
55. Albrecht T, Blomley MJ, Cosgrove DO et al: Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent. Lancet 353: 1579-1583, 1999
56. De Maria M, Midiri M, Iovane A et al: Epatopatie diffuse. In: De Maria M, Midiri M (eds). Imaging epato-biliare, pag 3-21, Gnocchi, Napoli, 1998
57. Kawamoto S, Soyer PA, Fishman EK, Bluemke DA Non neoplastic liver disease: evaluation with CT and MR Imaging. RadioGraphics 18: 827-835, 1998.
58. Lawson TL, Thorsen MK, Erickson SJ et al: Periportal halo: CT sign of liver disease. Abdomin Imaging 18: 42-47, 1993.
59. Siani A, Catalano O: Epatopatie diffuse. In: Siani A, Catalano O (eds): TC e TC spirale del fegato. Pag. 99-110, Idelson-Gnocchi, 2000.
60. Murakami T, Baron RL, Peterson MS: Liver necrosis and regeneration after fulminant hepatitis: pathologic correlation with CT and MR Imaging. Radiology 199: 505-511, 1996.
61. Heiken JP, Liver. In: Lee JKT, Sagel SS, Stanley RJ, Heiken JP: 701-777, Computed body tomography with MRI correlations Lippincott-Raven Philadelphia, 1998.
62. Joseph AEA, Saverymuttu SH, Al-Sam S et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol 43: 26-31, 1991.
63. Foley D, Jochem RJ: Computed tomography, Focal and diffuse liver disease. Radiol Clin North Am 29: 1213-1222, 1991.
64. Kroncke TJ, Taupitz M, Kivelitz D et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT imaging findings and diagnosis using MR imaging. Eur Radiol 10: 1095-1100, 2000
65. Apecella PL, Mirowitz SA, Weinreb JC: Extension of vessels through hepatic neoplasms: MR and CT findings. Radiology 191: 135-140, 1994.
66. Outwater EK, Blasbalg R, Siegelman ES et al: Detection of lipid in abdominal tissues with opposed-phase gradient echo images at 1 5 T: technique and diagnostic importance. RadioGraphics 18: 1465-1473, 1998.
67. Hirohashi S, Ueda Kouji, Hideo Uchida et al: Nondiffuse fatty change of the liver: discerning pseudotumor on MR images enhanced with ferumoxides-Initial observations. Radiology 217: 415-420, 2000.
68. Kuwatsuru R, Brasch RC, Muhler A et al Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents. Radiology 202: 131-138, 1997.
69. Powell LW. Haemocromatosis and related iron storage disease. In: Millward-Sadler J, Wright F, Arthur J (eds). Wright's liver and biliary disease, pag. 976-994, WB Saunders, London, 1992
70. Di Renzi P, Cianciulli P, Preziosi P et al. Accumulo di ferro nel fegato di pazienti con talassemia major valutato mediante Risonanza Magnetica con bassa intensità di campo: correlazione con i parametri clinico-strumentali. Radiol Med 91: 764-768, 1996.
71. Midiri M, Gallo C, Finazzo M et al: II fegato nei pazienti affetti da beta talassemia major Determinazione della concentrazione di ferro con Risonanza Magnetica. Radiol Med 97: 60-64, 1999.
72. Gandon Y, Guyader D, Heautot JF et al. Hemochromatosis: Diagnosis and quantification of liver iron with Gradient-Echo MR Imaging. Radiology, 193: 533-538, 1994.
73. Arena L, Morehouse HT, Safir J: MR Imaging artefacts that simulate disease: how to recognize and eliminate them. RadioGraphics 15: 1373-1379, 1995.
74. Siegelman ES, Mitchell DG, Semelka R: Abdominal iron deposition: metabolism, MR findings and clinical importance. Radiology 199: 13-19, 1996.
75. Bonkovsky HL, Rubin RB, Cable EE et al: Hepatic iron concentration: non-invasive estimation by means of MR Imaging techniques. Radiology 212: 227-234, 1999.
76. Ernst O, Sergent G, Bonvarlet P et al Hepatic iron overload: diagnosis and quantification with MR imaging. AJR 168: 1205-1208, 1997.
77. Angelucci E, Giovagnoni A, Valeri G et al: limitations of Magnetic Resonance Imaging in measurement of hepatic iron. Blood 90: 4736-4742, 1997.
78. Nelson RC: Diffuse hepatic disease. In: Fishman EK, Federle MP (eds). Body CT. Pag. 89-95. American Roentgen Ray Society, New York, 1994.
79. Tani I, Kurihara Y, Kawaguchi A et al: MR imaging of Diffuse Liver Disease. AJR 174: 965-971, 2000.
80. Fishman EK, Bluemke DA. Vascular and inflammatory diseases of the liver. In: Freeny PC, Dodd III GD, Cooperberg PL, Ros PR (eds). Radiology of the liver, biliary tract and pancreas. Pag 55-63, American Roentgen Ray Society, New York, 1996.
81. Mergo PJ, Ros PR, Buetow CP, Buck JL: Diffuse diseases of the liver: radiologic-pathologic correlation. RadioGraphics 14: 1291-1307, 1994
82. Soyer P, Rabenandrasana A, Barge J et al: MRI of Budd-Chiari syndrome. Abdon Imagin 19: 325-329, 1994
83. De Maria M, De Simone G, Laconi A et al: Gold storage in the liver: appearance on CT scans. Radiology 159: 355-356, 1986.